DISOPYRAMIDE HEMODIALYSIS AND KINETICS IN PATIENTS REQUIRING LONG-TERM HEMODIALYSIS

被引：8

作者：

SEVKA, MJ

MATTHEWS, SJ

NIGHTINGALE, CH

IZARD, MW

FIELDMAN, A

CHOW, MSS

机构：

[1] HARTFORD HOSP,DEPT PHARM,HARTFORD,CT 06115

[2] HARTFORD HOSP,DEPT MED,HARTFORD,CT 06115

[3] UNIV CONNECTICUT,DEPT PHARM,STORRS,CT 06268

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 03期

关键词：

D O I：

10.1038/clpt.1981.43

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：322 / 326

页数：5

共 11 条

[1] DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY [J].

BRYSON, SM ;

WHITING, B ;

LAWRENCE, JR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :409-419

[2] EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J].

CUNNINGHAM, JL ;

SHEN, DD ;

SHUDO, I ;

AZARNOFF, DL .

CLINICAL PHARMACOKINETICS, 1977, 2 (05) :373-383

[3]

DANILO P, 1976, AM HEART J, V92, P532

[4] DISOPYRAMIDE PHARMACOKINETICS AND BIOAVAILABILITY [J].

DUBETZ, DK ;

BROWN, NN ;

HOOPER, WD ;

EADIE, MJ ;

TYRER, JH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) :279-281

[5]

FLOOD JG, 1980, CLIN CHEM, V26, P197

[6] PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE [J].

HINDERLING, PH ;

BRES, J ;

GARRETT, ER .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) :1684-1690

[7]

HORN JR, 1978, LANCET, V2, P214

[8]

KARIM A, 1975, ANGIOLOGY, V26, P85

[9] DRUG-THERAPY - DISOPYRAMIDE [J].

KOCHWESER, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (17) :957-962

[10] CSTRIP, A FORTRAN-4 COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].

SEDMAN, AJ ;

WAGNER, JG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (07) :1006-1010

← 1 2 →